(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...heapprovalofallofits,"firstday"motionsbytheU.S.Ban...cyCourt").deCODElastweekfiledavoluntarypetitionfor...dewiththe,BankruptcyCourt. , Theordersissuedb...rateitsbusinessduringtheChapter11proceedings.Inpar...
(Date:11/24/2009)...ANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyann...SFDA)hasapprovedthe,investigationalnewdrugapplicat...tiveinsulinformulationtotreatdiabetes.ThisIND,appr...tudy. , Diabetesisadisordercharacteristicofhi...fdiabetesoftenresultinseveremicro-and,macro-vascul...
(Date:11/24/2009)...imaryefficacyendpointhasbeenmetforpatientswithadva...EBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZenta...albiopharmaceuticalcompanyfocusedonendocrinetherap...maPhase2studywithitstargetedcytotoxicpeptideconjug...dorrecurrentendometrialcancer.Inapersonalizedhealt...
(Date:11/24/2009)...NDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPha...atthecompanyisscheduledtopresentatthePiperJaffray2...30a.m.EasternTime(8:30a.m.PacificTime)attheNewYork...t andChiefExecutiveOfficer,isscheduledtoprovideano...tanddiscoveryprograms. ,, Aliveaudiowebcastofth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2...FRANCISCO, Calif., May 14 VaxGen,Inc. (OTC Bullet...y,provided guidance on its expected monthly cash e...g undertaken on April 9, 2008. VaxGen expects that...rd are unlikely to exceed,$1 million, made up of t... Company,s real estate and facility, estimated at ...
... May 14 Sigma-Aldrich (Nasdaq:,SIAL) announced to...nancial,Officer Michael R. Hogan will retire at a ...ed 55 in April, had notified the Company early thi...essor could be identified,and successfully transit...ify a successor from a pool of internal and extern...
...mer,s Study Group Outlines a National Plan, WASHI...ustice Sandra Day O,Connor and Former Speaker of t...ecial hearing of the U.S. Senate,Special Committee...hl,(D-WI) specifically to hear updates on the figh...Connor,s first public statement about her,commitme...
Other Biology Technology:Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 3Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway 2Retired Supreme Court Justice Sandra Day O'Connor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimer's Disease 2Retired Supreme Court Justice Sandra Day O'Connor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimer's Disease 3...system combines world-class performance hardware, ...ftware, Agilents world-renowned support and column...lies--a combination that lets you reach uncompromi...sed on dependable data. The Agilent 6820 GC system...
7890A GC from Agilent Technologies
RF-5301 Fluorescence Spectrophotometer from Shimadzu
Kit for BASE20/50 dual control unit KIT50EHTD from Wave Biotech now part of GE Healthcare
Biology Products: